Target Name: SEMG1
NCBI ID: G6406
Other Name(s): FLJ78262 | Semenogelin-1 | CT103 | semenogelin 1 | MGC14719 | Semen coagulating protein | Cancer/testis antigen 103 | Alpha-inhibin-92 | cancer/testis antigen 103 | SEMG1_HUMAN | Seminal basic protein | Alpha-inhibin-31 | Semenogelin I | SEMG | SgI-29 | semen coagulating protein | dJ172H20.2 | Semenogelin 1 | SGI | semenogelin I

SEMG1: A Potential Drug Target for Cancer

SEMG1 (FLJ78262) is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. Its primary function is to regulate the structure and function of actin filaments, which are a type of protein that plays a critical role in the mechanical properties of cells. SEMG1 has also been shown to be involved in the regulation of cell migration and the development of cancer.

SEMG1 has been identified as a potential drug target due to its involvement in several important cellular processes. For example, SEMG1 has been shown to play a role in the regulation of actin filament dynamics, which are critical for the proper functioning of many cellular processes. SEMG1 has also been shown to be involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and the development of tissues.

In addition to its role in cellular processes, SEMG1 has also been shown to play a role in the development of cancer. For example, studies have shown that SEMG1 is often overexpressed in many types of cancer, which suggests that it may be a useful biomarker for the diagnosis and treatment of these diseases.

SEMG1 has also been shown to be involved in the regulation of many different cellular processes, including cell division, cell migration, and cell adhesion. Its primary function is to regulate the structure and function of actin filaments, which are a type of protein that plays a critical role in the mechanical properties of cells. SEMG1 has also been shown to be involved in the regulation of cell signaling pathways, which are critical for the proper functioning of many cellular processes.

SEMG1 has been shown to play a role in the regulation of actin filament dynamics, which are critical for the proper functioning of many cellular processes. SEMG1 has also been shown to be involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and the development of tissues.

In addition to its role in cellular processes, SEMG1 has also been shown to play a role in the development of cancer. Studies have shown that SEMG1 is often overexpressed in many types of cancer, which suggests that it may be a useful biomarker for the diagnosis and treatment of these diseases.

Overall, SEMG1 is a protein that has been shown to play a critical role in a variety of cellular processes. Its functions include regulating actin filament dynamics, cell adhesion, and cell signaling pathways. As a result, SEMG1 has been identified as a potential drug target and may be a useful biomarker for the diagnosis and treatment of many types of cancer.

Protein Name: Semenogelin 1

Functions: Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA

More Common Targets

SEMG2 | SENCR | SENP1 | SENP2 | SENP3 | SENP3-associated complex | SENP3-EIF4A1 | SENP5 | SENP6 | SENP7 | SENP8 | SEPHS1 | SEPHS1P4 | SEPHS1P6 | SEPHS2 | SEPSECS | SEPSECS-AS1 | SEPT5-GP1BB | SEPTIN1 | SEPTIN10 | SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3